In an exciting development for the healthcare technology landscape, Ada Health, the global health company renowned for its innovative symptom assessment app, has successfully raised an impressive $90 million in its latest funding round. Founded by a team of visionary doctors, Ada is dedicated to transforming medical knowledge into actionable insights that lead to improved health outcomes for individuals worldwide. With a robust user base of 13 million and over 32 million assessments completed, Ada stands as the world's most popular symptom assessment tool, with a new user seeking guidance every three seconds. This significant funding boost will be instrumental in further advancing Ada's powerful enterprise solutions, which are designed to support healthcare systems, insurers, and various organizations in making informed health decisions, efficiently triaging patients to appropriate care, and reducing unnecessary costs. The influx of capital will allow Ada to expand its reach and enhance its capabilities, ultimately aiming to empower more people across the globe to take charge of their health with confidence. As the healthcare industry continues to evolve and the demand for digital health solutions rises, Ada Health's commitment to improving human health through intelligent technology marks a critical step forward in the quest for better healthcare accessibility and efficiency. This funding round not only validates Ada's impact on the health tech sector but also positions the company to further innovate and lead as a key player in prioritizing patient-centered care and improved health outcomes.
Ada Health Secures $90 Million in Series B Funding to Revolutionize Global Healthcare
Get the full Ada Health company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today
Replenish, Inc.
Replenish, Inc. developed the world's smallest implantable, refillable drug pump for the $7 billion retinal therapeutic market (pump currently in clinical investigation, not yet approved by FDA for sale). The MicroPump is implanted under the eye's skin for the purpose of periodically injecting sight-saving medication for patients with age related macular degeneration (AMD). After a 20 minute outpatient surgical procedure, the pump is programmed and recharged wirelessly by the physician and refilled ever 6 months to deliver biotech protein therapies that could only be otherwise administered by a physician's syringe every 4 weeks for life. See our website at www.replenishinc.com for more information.
$100.0K Unknown
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Isomorphic Labs United Kingdom | Series b | $2.1B | today |
| 2 |  Invert Robotics Ireland | Series b | $2.7M | today |
| 3 |  Catch Co. United States | Series b | $38.0M | today |
| 4 |  Tarsus Pharmaceuticals, Inc. United States | Series b | $60.0M | today |
| 5 |  Aclaris Therapeutics, Inc. United States | Series b | $21.0M | today |